Invitris Patents

Patent portfolio assigned to Invitris (verified via public assignee records). Estimated patent count: 1. Germany (Munich) TUM spin-off biotech: cell-free in-vitro synthesis of phages/antimicrobial proteins. has_patents=true — patent WO2025196126A1 'Multispecific particles' lists assignee Invitris GmbH (inventors Vogele & Grossmann, priority 2024-03-19), surfaced via Google Patents in search. Count is at least 1 (>=1 confirmed). No customers or competitors named on public materials.